DrugPatentWatch Database Preview
DOXAPRAM HYDROCHLORIDE Drug Profile
see a sample report or, see our see our flat-rate plans
When do Doxapram Hydrochloride patents expire, and what generic alternatives are available?
The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
Summary for DOXAPRAM HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Bulk Api Vendors: | 33 |
| Clinical Trials: | 7 |
| Patent Applications: | 158 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DOXAPRAM HYDROCHLORIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for DOXAPRAM HYDROCHLORIDE
Synonyms for DOXAPRAM HYDROCHLORIDE
| (+-)-1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate |
| 081D530 |
| 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrochloride |
| 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate |
| 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate |
| 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride |
| 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride |
| 113-07-5 |
| 113D075 |
| 2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride |
| 2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate |
| 2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate, (+-)- |
| 2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride |
| 2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate |
| 2-Pyrrolidinone,3-diphenyl-, monohydrochloride |
| 3,3-Diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone hydrochloride |
| AC-4694 |
| AC1L21NE |
| AHR 619 |
| AHR-619 |
| AK-55670 |
| AKOS015906444 |
| AOB5785 |
| API0002485 |
| AS-13336 |
| Bio-0166 |
| C24H30N2O2 |
| C24H30N2O2.HCl |
| CAS-113-07-5 |
| CCG-101076 |
| CCG-221205 |
| CHEBI:59837 |
| CHEMBL1200876 |
| CPD000469229 |
| CTK8F9367 |
| Doxapram HCL |
| Doxapram hydrochloride [USAN:JAN] |
| Doxapram hydrochloride anhydrous |
| DSSTox_CID_27815 |
| DSSTox_GSID_47837 |
| DSSTox_RID_82579 |
| DTXSID9047837 |
| EINECS 204-022-3 |
| FC1271 |
| H927 |
| J-002892 |
| K-0985 |
| LS-138812 |
| MBGXILHMHYLZJT-UHFFFAOYSA-N |
| MCULE-1905124271 |
| MFCD00072148 |
| MLS001424142 |
| MolPort-005-973-141 |
| NC00326 |
| NCGC00167459-01 |
| NCGC00167459-02 |
| NSC-170958 |
| NSC170958 |
| SAM001246792 |
| SCHEMBL40645 |
| SMR000469229 |
| Stimulexin |
| Tox21_112463 |
| Tox21_112463_1 |
US Patents and Regulatory Information for DOXAPRAM HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Athenex Inc | DOXAPRAM HYDROCHLORIDE | doxapram hydrochloride | INJECTABLE;INJECTION | 076266-001 | Jan 10, 2003 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Watson Labs | DOXAPRAM HYDROCHLORIDE | doxapram hydrochloride | INJECTABLE;INJECTION | 073529-001 | Jan 30, 1992 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
